联系方式：
MK-7246产品描述：MK-7246 is a potent and selective CRTH2 antagonist with a K_i of 2.5±0.5 nM.IC50 & Target: Ki: 2.5±0.5 nM (CRTH2), 373±96 nM (Prostaglandin D, DP), 7668±2169 nM (Prostaglandin E2, EP₂), 3804±1290 nM (TXA2,TP)^[1]In Vitro: The affinity and selectivity of MK-7246 for human CRTH2 and recombinant human prostanoid receptors is determined by equilibrium competition analysis using the relevant radioligands and cell membranes expressing the various receptors. MK-7246 competes for [³H]PGD₂ specific binding to cell membranes expressing recombinant human CRTH2 with high-affinity (K_i, 2.5 nM). MK-7246 displays a relatively high selectivity for CRTH2 with an affinity 149-fold lower for the DP receptor (K_i, 373±96 nM) and ≥1500-fold lower for the other prostanoid receptors (K_i, 7668±2169 nM for EP₂, 3804±1290 nM for TP). MK-7246 is also tested in a panel of 157 enzyme and receptor assays at concentrations up to 100 μM and small but significant activity is detected only on phosphodiesterase 1 (PDE1, IC₅₀=33.2 μM) and MAPK3 (ERK1, IC₅₀=49.4 μM)^[1].In Vivo: Whether the inhibition of a clinically-relevant mechanism of allergic lung inflammation such as CRTH2 will lead to a suppression of inflammatory responses is investigated in A. alternata challenged Brown Norway rats (n=8 per group). Mast cell derived production of Prostaglandin D₂ (PGD₂) is believed to be a prime mediator of allergic inflammation. Since CRTH2 plays an important role in the early aspects of the allergic inflammation cascade, the effect of the CRTH2 antagonist is examined on A. alternate elicited pulmonary inflammatory responses. CRTH2 inhibitor MK-7246 is orally administered 1 h before and 23 h post-intratracheal instillation of the A. alternata. MK-7246 produces a dose dependent decrease in the number of eosinophils with a maximal inhibition of 74±5% in the 100 mg/kg group (P<0.05), IL-5 (80±12%) and IL-13 (76±14%) cytokines levels (P<0.05) ^[2].
产品链接：www.medchemexpress.com/MK-7246.html

研究领域：GPCR/G Protein

靶点：Prostaglandin Receptor

相关产品：Prostaglandin E1  |  Prostaglandin E2  |  Grapiprant  |  NS-304  |  PF-04418948  |  TG6-10-1  |  Fevipiprant  |  Terutroban  |  ONO-AE3-208  |  Taprenepag  |  GW627368  |  Laropiprant  |  Ramatroban  |  Setipiprant  |  CJ-42794  |  



公司介绍：MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库，总部位于美国新泽西，分别在瑞典和上海设有欧洲区子公司和亚洲区总代理，营销网点遍及全球20多个国家地区。MCE经过多年努力已成为全球生物活性小分子领域的一流供应商， 产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域，PI3K、MAPK等近千个细分靶点，超过4000个活性小分子化合物现货，以及GPCR、API、离子通道等超过20种不同类型的化合物库，同时提供从毫克到千克的专业定制合成服务。
MCE 对每批产品都进行严格的LCMS和NMR检验，其产品已被全球近万名客户广泛使用并发表大量文章、；
MCE 定期增加各领域热门抑制剂、激动剂，不断扩增已有化合物库，以满足*新的科研需求；
数千种产品在上海有充足备货，24-48小时内送达客户；
大量产品提供免费试用装；已为全球多个知名企业、院校构建各种定制型化合物库。

联系方式：